Please provide your email address to receive an email when new articles are posted on . The FDA approved a 200 mg Benlysta autoinjector for children aged 5 years and ...

With this approval, pediatric patients aged five years and older with active lupus nephritis will have a first-of-its-kind treatment option for at-home administration. Lupus nephritis is one of the ...

FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis By Lori Solomon HealthDay ReporterMONDAY, June 30, 2025 (HealthDay News) -- The U.S. Food and Drug Administration ...

GSK plc (NYSE:GSK) is one of the 11 best European stocks to invest in. On June 24, the company announced receipt of FDA approval for a 200 mg/mL autoinjector of Benlysta (belimumab) for the treatment ...

Benlysta is a human monoclonal antibody that was approved for the treatment of lupus in adults by the U.S. Food and Drug Administration (FDA) in 2011 and for lupus nephritis in adults in 2020.

The approval makes belimumab (Benlysta) the first at-home treatment in its class for patients 5 years and older with systemic lupus erythematosus (SLE). The FDA approved GSK’s belimumab (Benlysta) ...

People with lupus often need to use medicines to manage their symptoms. Although there are many oral medicines that treat lupus, some people with more severe symptoms may not get enough benefit from ...

The 200mg single-dose prefilled autoinjector allows pediatric patients to receive LN treatment at home via SC administration. The Food and Drug Administration (FDA) has approved Benlysta (belimumab), ...

The 200mg single-dose prefilled autoinjector allows pediatric patients to receive SLE treatment at home via SC administration. The Food and Drug Administration (FDA) has approved Benlysta (belimumab) ...

If you can become pregnant, it’s important to consider whether Benlysta is a safe choice for you. Monoclonal antibodies, such as belimumab (the active drug in Benlysta), may affect the immune system ...

Benlysta represents a breakthrough in the treatment of lupus. Benlysta is the first drug approved to treat lupus in more than 50 years AND is the first drug developed specifically for lupus since the ...